Light Physical Activity Linked to Improved Vascular Parameters in RA
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 5, 2024 -- Sedentary behavior (SB) is negatively associated and light physical activity (PA) is positively associated with vascular parameters among postmenopausal women with rheumatoid arthritis (RA), according to a study published online Nov. 1 in the American Journal of Physiology: Heart and Circulatory Physiology.
Kamila Meireles, from the Universidade de São Paulo in Brazil, and colleagues conducted a cross-sectional study involving 82 postmenopausal women with RA who underwent ultrasound assessments of vascular function and structure, including brachial and superficial femoral artery (BA and SFA) flow-mediated dilation; baseline and posthyperemia peak diameters; and carotid intima-media thickness. Participants also underwent a seven-day accelerometer-based assessment of PA and SB to examine the associations with vascular health markers.
The researchers found that prolonged SB (bouts > 60 minutes) and total sedentary time were inversely associated with baseline and peak BA diameters, with decreases of 0.08 to 0.1 mm in these diameters with each additional hour of SB. Similar negative associations were seen for total sedentary time with peak SFA diameters (β = −0.14). In contrast, positive associations were seen for light-intensity PA and stepping time with both baseline and peak BA diameters, with a 0.10- to 0.24-mm increase in these diameters with each additional hour. A positive association was seen for standing time with SFA peak diameter (β = 0.11). Moderate-to-vigorous PA was not associated with vascular outcomes.
"Our results suggest the potential role of replacing sedentary behavior with light physical activity to improve vascular health markers in RA," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-06 12:00
Read more
- Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds, Wegovy, Zepbound, for Employees
- Adult Hypertension Prevalence 47.7 Percent From August 2021 to August 2023
- Most Older Americans Don't Trust AI-Generated Health Info, Survey Finds
- New Hope Against a Rare, Aggressive Form of Thyroid Cancer
- ASN: Hypertension Most Common Cardiovascular Comorbidity Seen With Dialysis
- Could Certain Genes Help You Slim Down?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions